Role of imaging in cardiac stem cell therapy

被引:128
作者
Beeres, Saskia L. M. A.
Bengel, Frank M.
Bartunek, Jozef
Atsma, Douwe E.
Hill, Jonathan M.
Vanderheyden, Marc
Penicka, Martin
Schalij, Martin J.
Wijns, William
Bax, Jeroen J.
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[2] Johns Hopkins Univ, Sch Med, Div Nucl Med, Baltimore, MD USA
[3] Cardiovasc Ctr Aalst, Aalst, Belgium
[4] Kings Coll London, Dept Cardiovasc Dis, London WC2R 2LS, England
[5] Charles Univ Prague, Med Sch 3, Cardioctr, Prague, Czech Republic
[6] Univ Hosp, Prague, Czech Republic
关键词
D O I
10.1016/j.jacc.2006.10.072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Stem cell therapy has emerged as a potential therapeutic option for cell death-related heart diseases. Preclinical and a number of early phase human studies suggested that cell therapy may augment perfusion and increase myocardial contractility. The rapid translation into clinical trials has left many issues unresolved, and emphasizes the need for specific techniques to visualize the mechanisms involved. Furthermore, the clinical efficacy of cell therapy remains to be proven. Imaging allows for in vivo tracking of cells and can provide a better understanding in the evaluation of the functional effects of cell-based therapies. In this review, a summary of the most promising imaging techniques for cell tracking is provided. Among these are direct labeling of cells with super-paramagnetic agents, radionuclides, and the use of reporter genes for imaging of transplanted cells. In addition, a comprehensive summary is provided of the currently available studies investigating a cell therapy-related effect on left ventricular function, myocardial perfusion, scar tissue, and myocardial viability.
引用
收藏
页码:1137 / 1148
页数:12
相关论文
共 59 条
  • [21] Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease - A feasibility study
    Fuchs, S
    Satler, LF
    Kornowski, R
    Okubagzi, P
    Weisz, G
    Baffour, R
    Waksman, R
    Weissman, NJ
    Cerqueira, M
    Leon, MB
    Epstein, SE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) : 1721 - 1724
  • [22] Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease
    Fuchs, S
    Kornowski, R
    Weisz, G
    Satler, LF
    Smits, PC
    Okubagzi, P
    Baffour, R
    Aggarwal, A
    Weissman, NJ
    Cerqueira, M
    Waksman, R
    Serrruys, P
    Battler, A
    Moses, JW
    Leon, MB
    Epstein, SE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (06) : 823 - 829
  • [23] Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells
    Hill, JM
    Dick, AJ
    Raman, VK
    Thompson, RB
    Yu, ZX
    Hinds, KA
    Pessanha, BSS
    Guttman, MA
    Varney, TR
    Martin, BJ
    Dunbar, CE
    McVeigh, ER
    Lederman, RJ
    [J]. CIRCULATION, 2003, 108 (08) : 1009 - 1014
  • [24] Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells
    Hinds, KA
    Hill, JM
    Shapiro, EM
    Laukkanen, MO
    Silva, AC
    Combs, CA
    Varney, TR
    Balaban, RS
    Koretsky, AP
    Dunbar, CE
    [J]. BLOOD, 2003, 102 (03) : 867 - 872
  • [25] Monitoring of bone marrow cell homing into the infarcted human myocardium
    Hofmann, M
    Wollert, KC
    Meyer, GP
    Menke, A
    Arseniev, L
    Hertenstein, B
    Ganser, A
    Knapp, WH
    Drexler, H
    [J]. CIRCULATION, 2005, 111 (17) : 2198 - 2202
  • [26] Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction
    Ingkanisorn, WP
    Rhoads, KL
    Aletras, AH
    Kellman, P
    Arai, AE
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 2253 - 2259
  • [27] Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial
    Janssens, S
    Dubois, C
    Bogaert, J
    Theunissen, K
    Deroose, C
    Desmet, W
    Kolantzi, M
    Herbots, L
    Sinnaeve, P
    Dens, J
    Maertens, J
    Rademakers, F
    Dymarkowski, S
    Gheysens, O
    Van Cleemput, J
    Bormans, G
    Nuyts, J
    Belmans, A
    Mortelmans, L
    Boogaerts, M
    Van de Werf, F
    [J]. LANCET, 2006, 367 (9505) : 113 - 121
  • [28] Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial
    Kang, HJ
    Kim, HS
    Zhang, SY
    Park, KW
    Cho, HJ
    Koo, BK
    Kim, YJ
    Lee, DS
    Sohn, DW
    Han, KS
    Oh, BH
    Lee, MM
    Park, YB
    [J]. LANCET, 2004, 363 (9411) : 751 - 756
  • [29] Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium
    Katritsis, DG
    Sotiropoulou, PA
    Karvouni, E
    Karabinos, I
    Korovesis, S
    Perez, SA
    Voridis, EM
    Papamichail, M
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (03) : 321 - 329
  • [30] Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
    Kocher, AA
    Schuster, MD
    Szabolcs, MJ
    Takuma, S
    Burkhoff, D
    Wang, J
    Homma, S
    Edwards, NM
    Itescu, S
    [J]. NATURE MEDICINE, 2001, 7 (04) : 430 - 436